Oaktree Acquisition Corp. III Life Sciences (OACC) Competitors $10.57 +0.06 (+0.57%) As of 10/17/2025 03:55 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OACC vs. PAX, UNIT, FBRT, GETY, NXRT, PBT, NOAH, PRPB, APPS, and VINPShould you be buying Oaktree Acquisition Corp. III Life Sciences stock or one of its competitors? The main competitors of Oaktree Acquisition Corp. III Life Sciences include Patria Investments (PAX), Uniti Group (UNIT), Franklin BSP Realty Trust (FBRT), Getty Images (GETY), NexPoint Residential Trust (NXRT), Permian Basin Royalty Trust (PBT), Noah (NOAH), CC Neuberger Principal Holdings II (PRPB), Digital Turbine (APPS), and Vinci Compass Investments (VINP). These companies are all part of the "trading" industry. Oaktree Acquisition Corp. III Life Sciences vs. Its Competitors Patria Investments Uniti Group Franklin BSP Realty Trust Getty Images NexPoint Residential Trust Permian Basin Royalty Trust Noah CC Neuberger Principal Holdings II Digital Turbine Vinci Compass Investments Patria Investments (NYSE:PAX) and Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) are both small-cap trading companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and risk. Do analysts rate PAX or OACC? Patria Investments presently has a consensus target price of $14.00, suggesting a potential downside of 3.31%. Given Patria Investments' stronger consensus rating and higher possible upside, equities analysts plainly believe Patria Investments is more favorable than Oaktree Acquisition Corp. III Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Patria Investments 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Oaktree Acquisition Corp. III Life Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Do institutionals & insiders hold more shares of PAX or OACC? 96.3% of Patria Investments shares are held by institutional investors. 58.1% of Patria Investments shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is PAX or OACC more profitable? Patria Investments has a net margin of 19.91% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. Patria Investments' return on equity of 38.68% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Patria Investments19.91% 38.68% 15.84% Oaktree Acquisition Corp. III Life Sciences N/A N/A N/A Does the media refer more to PAX or OACC? In the previous week, Patria Investments had 4 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 4 mentions for Patria Investments and 0 mentions for Oaktree Acquisition Corp. III Life Sciences. Patria Investments' average media sentiment score of 0.93 beat Oaktree Acquisition Corp. III Life Sciences' score of 0.88 indicating that Patria Investments is being referred to more favorably in the media. Company Overall Sentiment Patria Investments Positive Oaktree Acquisition Corp. III Life Sciences Positive Which has higher earnings and valuation, PAX or OACC? Patria Investments has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPatria Investments$397.39M2.42$73.40M$0.5625.86Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A SummaryPatria Investments beats Oaktree Acquisition Corp. III Life Sciences on 11 of the 11 factors compared between the two stocks. Get Oaktree Acquisition Corp. III Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for OACC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OACC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OACC vs. The Competition Export to ExcelMetricOaktree Acquisition Corp. III Life SciencesInvestment Offices IndustryFinancial SectorNASDAQ ExchangeMarket Cap$235.69M$250.04M$4.83B$10.49BDividend YieldN/AN/A4.32%4.80%P/E RatioN/AN/A1,287.8227.13Price / SalesN/AN/A1,438.98179.96Price / CashN/A18,602.50127.7861.22Price / BookN/AN/A3.536.52Net IncomeN/A$12.92M$1.22B$276.93M7 Day PerformanceN/A0.17%-0.31%1.93%1 Month Performance0.86%2.79%0.65%2.19%1 Year PerformanceN/A6.27%40.34%34.99% Oaktree Acquisition Corp. III Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OACCOaktree Acquisition Corp. III Life SciencesN/A$10.57+0.6%N/AN/A$235.69MN/A0.00N/AHigh Trading VolumePAXPatria Investments2.6864 of 5 stars$13.80-1.6%$14.00+1.4%+26.1%$918.00M$397.39M27.60390UNITUniti Group2.3622 of 5 stars$5.73-5.1%$6.56+14.5%-1.2%$893.82M$1.17B20.83750FBRTFranklin BSP Realty Trust3.7156 of 5 stars$10.59+0.2%$14.67+38.5%-18.3%$869.65M$516.24M10.81N/AGETYGetty Images3.0275 of 5 stars$2.08-5.9%$4.03+93.5%-46.5%$866.96M$946.83M-7.431,700Trending NewsAnalyst UpgradeNXRTNexPoint Residential Trust4.5004 of 5 stars$30.89-1.8%$40.88+32.3%-31.6%$798.22M$259.70M-15.763Positive NewsPBTPermian Basin Royalty Trust1.4437 of 5 stars$17.48+3.2%N/A+41.3%$789.55M$26.96M48.56N/APositive NewsHigh Trading VolumeNOAHNoah3.3543 of 5 stars$11.00-7.3%$12.00+9.1%-6.5%$784.88M$356.33M9.821,990Dividend CutPRPBCC Neuberger Principal Holdings IIN/A$2.09-5.4%N/A-46.0%$774.18MN/A0.004APPSDigital Turbine2.235 of 5 stars$6.25-7.7%$5.17-17.3%+99.1%$733.70M$490.51M-8.12840VINPVinci Compass Investments3.7218 of 5 stars$10.82-0.8%$13.33+23.2%+8.9%$698.75M$111.41M23.02240High Trading Volume Related Companies and Tools Related Companies Patria Investments Competitors Uniti Group Competitors Franklin BSP Realty Trust Competitors Getty Images Competitors NexPoint Residential Trust Competitors Permian Basin Royalty Trust Competitors Noah Competitors CC Neuberger Principal Holdings II Competitors Digital Turbine Competitors Vinci Compass Investments Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OACC) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredHoly ****... This could actually MAGAA new document circulating from Washington is stirring major controversy — one that some say could redefine Am...StocksToTrade | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredA Worldwide Gold Lockdown Is Now UnderwayCentral banks around the world are hoarding gold at one of the fastest rates in history — and former Goldman S...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. III Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition Corp. III Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
